Actinium Pharmaceuticals Inc (ATNM)

7.04 +0.08 (+1.15%) USD  |  NYAM  |  Apr 24, 16:00
7.04 0.00 (0.00%) After-Hours: 20:00
More

Actinium Pharmaceuticals PE Ratio

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2011. Upgrade now.
Date Value
September 02, 2011 544.37
September 01, 2011 544.37
August 31, 2011 544.37
August 30, 2011 544.37
August 29, 2011 544.37
August 26, 2011 544.37
August 25, 2011 544.37
August 24, 2011 544.37
Date Value
August 23, 2011 544.37
August 22, 2011 544.37
August 19, 2011 544.37
August 18, 2011 544.37
August 17, 2011 544.37
August 16, 2011 544.37
August 15, 2011 544.37
August 12, 2011 544.37

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

Perspective Therapeutics Inc --
Eli Lilly and Co 128.71
Cellectar Biosciences Inc --
Bristol-Myers Squibb Co 12.66
Oragenics Inc --

PE Ratio Related Metrics

PEG Ratio -0.1146
Price to Book Value 5.689
Price 7.04
Earnings Yield -25.99%
Market Cap 206.95M
PEGY Ratio -0.1146